1. Home
  2. HRMY vs MCRI Comparison

HRMY vs MCRI Comparison

Compare HRMY & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • MCRI
  • Stock Information
  • Founded
  • HRMY 2017
  • MCRI 1972
  • Country
  • HRMY United States
  • MCRI United States
  • Employees
  • HRMY N/A
  • MCRI N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • MCRI Hotels/Resorts
  • Sector
  • HRMY Health Care
  • MCRI Consumer Discretionary
  • Exchange
  • HRMY Nasdaq
  • MCRI Nasdaq
  • Market Cap
  • HRMY 1.9B
  • MCRI 1.9B
  • IPO Year
  • HRMY 2020
  • MCRI 1993
  • Fundamental
  • Price
  • HRMY $26.87
  • MCRI $99.07
  • Analyst Decision
  • HRMY Strong Buy
  • MCRI Hold
  • Analyst Count
  • HRMY 10
  • MCRI 5
  • Target Price
  • HRMY $51.30
  • MCRI $96.20
  • AVG Volume (30 Days)
  • HRMY 1.0M
  • MCRI 88.3K
  • Earning Date
  • HRMY 10-28-2025
  • MCRI 10-22-2025
  • Dividend Yield
  • HRMY N/A
  • MCRI 1.21%
  • EPS Growth
  • HRMY 58.41
  • MCRI N/A
  • EPS
  • HRMY 3.10
  • MCRI 4.22
  • Revenue
  • HRMY $772,527,000.00
  • MCRI $534,693,999.00
  • Revenue This Year
  • HRMY $19.94
  • MCRI $6.87
  • Revenue Next Year
  • HRMY $16.65
  • MCRI $4.19
  • P/E Ratio
  • HRMY $8.72
  • MCRI $23.51
  • Revenue Growth
  • HRMY 17.74
  • MCRI 4.65
  • 52 Week Low
  • HRMY $26.26
  • MCRI $69.99
  • 52 Week High
  • HRMY $41.61
  • MCRI $113.88
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 27.45
  • MCRI 36.87
  • Support Level
  • HRMY $26.56
  • MCRI $103.32
  • Resistance Level
  • HRMY $27.48
  • MCRI $107.00
  • Average True Range (ATR)
  • HRMY 1.01
  • MCRI 2.33
  • MACD
  • HRMY -0.25
  • MCRI -0.59
  • Stochastic Oscillator
  • HRMY 8.99
  • MCRI 11.12

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About MCRI Monarch Casino & Resort Inc.

Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.

Share on Social Networks: